MoneyWorks4Me

Eiko Lifesciences informs about disclosure

22 Aug 2024 Evaluate
Eiko Lifesciences has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Godrej Industries 975.70
SRF 2316.55
BASF India 3248.55
Pidilite Inds. 1467.00
Tata Chemicals 606.15
View more..